Cellomatics BioSciences are pleased to announce their collaboration with RenaSci to support analyte/biomarker testing for their experimental services using Luminex's Multiple-Analyte Profiling (xMAP®) technology. This technology allows simultaneous analysis of up to 50 analytes from a single small sample allowing RenaSci to offer a wider range of assays and measurement of multiple analytes when plasma volume is limited.
About Cellomatics BioSciences
Cellomatics Biosciences Ltd. is a laboratory-based Contract Research Organisation (CRO) specialised in providing bespoke pre-clinical/early discovery laboratory services to support academic groups, pharmaceutical and biotechnology companies in their R&D studies and biomarker research. Our areas of therapeutic expertise include oncology, immunology/inflammation and respiratory.Contact: firstname.lastname@example.org
RenaSci Ltd is an independent company offering an integrated blend of consultancy and pre-clinical experimental services to the pharmaceutical industry. Our clients include pharma, biotech, virtual companies, and healthcare investors worldwide and we collaborate with them on all aspects of drug discovery and development. Established in 2001, we focus on 4 key areas: abuse and dependence, CNS, obesity and diabetes.Contact: email@example.com
To download a case study report on the measurement of multiple plasma analytes using xMAP® technology please click here